Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;65(6):528-33.
doi: 10.1136/thx.2009.119347.

A Prospective Study of Respiratory Symptoms Associated With Chronic Arsenic Exposure in Bangladesh: Findings From the Health Effects of Arsenic Longitudinal Study (HEALS)

Affiliations
Free PMC article

A Prospective Study of Respiratory Symptoms Associated With Chronic Arsenic Exposure in Bangladesh: Findings From the Health Effects of Arsenic Longitudinal Study (HEALS)

Faruque Parvez et al. Thorax. .
Free PMC article

Abstract

Background and aims: A prospective cohort study was conducted to evaluate the effect of arsenic (As) exposure from drinking water on respiratory symptoms using data from the Health Effects of Arsenic Exposure Longitudinal Study (HEALS), a large prospective cohort study established in Ariahazar, Bangladesh in 2000-2002. A total of 7.31, 9.95 and 2.03% of the 11 746 participants completing 4 years of active follow-up reported having a chronic cough, breathing problem or blood in their sputum, respectively, as assessed by trained physicians.

Methods: Cox regression models were used to estimate HRs for respiratory symptoms during the follow-up period in relation to levels of chronic As exposure assessed at baseline, adjusting for age, gender, smoking, body mass index, education and arsenic-related skin lesion status.

Results: Significant positive associations were found between As exposure and respiratory symptoms. As compared with those with the lowest quintile of water As level (<or=7 microg/l), the HRs for having respiratory symptoms were 1.27 (95% CI 1.09 to 1.48), 1.39 (95% CI 1.19 to 1.63), 1.43 (95% CI 1.23 to 1.68) and 1.43 (95% CI 1.22 to 1.68) for the second to fifth quintiles of baseline water As concentrations (7-40, 40-90, 90-178 and >178 microg/l), respectively. Similarly, the corresponding HRs in relation to the second to fifth quintiles of urinary arsenic were 1.10 (95% CI 0.94 to 1.27), 1.11 (95% CI 0.95 to 1.29), 1.29 (95% CI 1.11 to 1.49) and 1.35 (95% CI 1.16 to 1.56), respectively. These associations did not differ appreciably by cigarette smoking status.

Conclusions: This prospective cohort study found a dose-response relationship between As exposure and clinical symptoms of respiratory diseases in Bangladesh. In particular, these adverse respiratory effects of As were clearly evident in the low to moderate dose range, suggesting that a large proportion of the country's population may be at risk of developing serious lung diseases in the future.

Conflict of interest statement

Competing interests: None.

Similar articles

See all similar articles

Cited by 44 articles

See all "Cited by" articles

References

    1. Rahman MM, Chowdhury UK, Mukherjee SC, et al. Chronic arsenic toxicity in Bangladesh and West Bengal, India—a review and commentary. J Toxicol Clin Toxicol 2001;39:683–700 - PubMed
    1. Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995;55:1296–300 - PubMed
    1. Smith AH, Goycolea M, Haque R, et al. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 1998;147:660–9 - PubMed
    1. Celik I, Gallicchio L, Boyd K, et al. Arsenic in drinking water and lung cancer: a systematic review. 2008. Environ Res 2008;108:48–55 - PubMed
    1. Marshall G, Ferreccio C, Yuan Y, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 2007;99:920–8 - PubMed

Publication types

MeSH terms

Feedback